Inhibition of low- and high-threshold Ca2+ channels of human neuroblastoma IMR32 cells by Lambert-Eaton myasthenic syndrome (LEMS) IgGs

Neurosci Lett. 1994 Nov 7;181(1-2):50-6. doi: 10.1016/0304-3940(94)90558-4.

Abstract

IgGs from two LEMS patients applied to human neuroblastoma IMR32 cells reduced the density of low- (LVA; T) and high-threshold (HVA; L and N) Ba2+ currents by different percentages: 36% (LVA) and 56% (HVA) for one and 48% and 45% for the other. A pharmacological assay of IgGs action based on the block of L-type channel by nifedipine and on the delayed activation of N-type channel by noradrenaline, indicated a preferential inhibition of the N-type current in IMR32 cells (55% and 47% for the two patients). The L-type current, contributing to approximately one-third of the total, was also depressed by LEMS IgGs but to a minor degree (49% and 30%). Except for an increase of single N-type channel inactivation, LEMS antibodies preserved the elementary properties of single HVA channels, suggesting that the macroscopic current reduction after IgGs treatment is likely due to a decrease in the number of active HVA Ca2+ channels.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Calcium Channel Blockers / pharmacology*
  • Calcium Channels / drug effects
  • Calcium Channels / metabolism*
  • Calcium Channels / physiology
  • Differential Threshold
  • Electric Conductivity
  • Humans
  • Immunoglobulin G / pharmacology*
  • Lambert-Eaton Myasthenic Syndrome / blood*
  • Neuroblastoma / metabolism*
  • Neuroblastoma / pathology
  • Nifedipine / pharmacology
  • Norepinephrine / pharmacology
  • Tumor Cells, Cultured

Substances

  • Calcium Channel Blockers
  • Calcium Channels
  • Immunoglobulin G
  • Nifedipine
  • Norepinephrine

Grants and funding